Naloxone* recalls
The FDA has published 4 recalls involving Naloxone* since 2014. The latest was reported on 7 Jun 2023. Most were for sterility. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls4since 2014
Last 12 months0reported
Class I125% of total
Ongoing1latest 7 Jun 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 25%Class II 3 75%Class III 0 0%
Why naloxone* is recalled
Companies
Brands
By year
Ongoing naloxone* recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Naloxone Injection, USP 0.4 mg/mL, For Intravenous recalled by Akorn | Akorn | Potency & Assay | Nationwide |
All naloxone* recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Naloxone Injection, USP 0.4 mg/mL, For Intravenous recalled by Akorn | Akorn | Potency & Assay | Nationwide |
| Drug | CLASS II | Narcan (naloxone HCl) Nasal Spray 4 mg Two Pack This box recalledNarcan | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS I | Naloxone Hydrochloride Injection, USP, 0.4 mg/mL recalledNaloxone Hydrochloride | Hospira Inc Lake Forest | Particulate Matter | Nationwide |
| Drug | CLASS II | Naloxone HCL* 0.4MG/ML Injectable, all sizes recalled | Specialty Medicine Compounding Pharmacy | Sterility | MI |
Should you stop taking Naloxone*?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.